文献速递儿童呼吸儿童感染新生儿

五岁以下儿童社区获得性肺炎经鼻持续气道正压通气的多中心前瞻性研究

[Nasal continuous positive airway pressure ventilation in children with community-acquired pneumonia under five years of age: a prospective, multi-center clinical study].
PubMed 文献 · Zhonghua Er Ke Za Zhi · 2017-01-01

该多中心前瞻性研究纳入132例29日龄至5岁社区获得性肺炎患儿,评估经鼻持续气道正压通气(NCPAP)的安全性与有效性。NCPAP治疗成功率为93.2%,能显著改善氧合及高碳酸血症,且无严重不良反应;但合并基础病、拒奶、发绀、治疗前PaCO2高或PaO2/FiO2低的患儿治疗失败风险较高,需尽早有创通气。

要点

  • NCPAP治疗成功率达93.2%,耐受良好且无严重不良反应。
  • 成功组治疗后呼吸频率、心率、PaCO2显著下降,PaO2及PaO2/FiO2显著上升。
  • 合并基础病、拒奶、发绀、PaCO2高或PaO2/FiO2低者需警惕NCPAP失败。

核心结论

  • NCPAP通气安全有效,可改善社区获得性肺炎婴儿的氧合及高碳酸血症。
  • 对存在基础疾病、拒奶、发绀、PaCO2极高或PaO2/FiO2极低的患儿,NCPAP可能效果不佳,需尽早气管插管。

研究设计与样本

  • 多中心、前瞻性临床观察性研究,纳入2013年11月至2015年10月全国6家儿童医院收治的29日龄至5岁社区获得性肺炎患儿。
  • 共145例入选,剔除数据不完整13例,最终纳入132例。

主要发现

  • ≤12月龄患儿102例(77.3%),农村居民91例(68.9%)。
  • NCPAP治疗成功123例(93.2%);未成功9例(6.8%),均改为气管插管有创机械通气,其中好转出院5例,死亡4例(均为放弃治疗后死亡)。
  • 未成功组治疗前PaCO2高于成功组[(59±11)比(49±11)mmHg,t=-2.597,P=0.028],PaO2/FiO2低于成功组[(150±37)比(207±63)mmHg,t=2.697,P=0.008]。
  • 成功组NCPAP治疗2、8、24 h后呼吸频率、心率、PaCO2较治疗前显著下降(P均=0.000),PaO2、PaO2/FiO2显著上升(P均=0.000)。
  • 成功组中治疗前合并高碳酸血症患儿PaCO2显著下降[(48±9)、(47±12)、(45±11)比(58±7)mmHg,P均=0.000]。

关键数值与推荐

  • 未成功组合并基础病、拒奶、发绀的比例明显多于成功组(P均<0.05)。
  • 两组性别、年龄、体重、居住地、主要症状及阳性体征、影像学诊断、治疗前呼吸频率和心率、治疗前PaO2差异均无统计学意义(P均>0.05)。
  • 所有入选患儿对NCPAP耐受良好,无不良事件或并发症。

临床怎么用

  • 对符合NCPAP指征的5岁以下社区获得性肺炎患儿,可规范使用NCPAP以改善氧合及高碳酸血症。
  • 若患儿合并基础病、出现拒奶或发绀、治疗前PaCO2明显升高或PaO2/FiO2明显降低,应警惕NCPAP失败,尽早考虑有创通气。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To analyze the clinical characteristics of community-acquired pneumonia (CAP) in children under five years of age and analyze the safety and efficiency of nasal continuous positive airway pressure (NCPAP) ventilation for CAP in this population. Method: This was a prospective multicenter study. Children who were admitted to these six centers with CAP and met the NCPAP ventilation indications, aged from 29 d to 5 years, were continuously included during November 2013 to October 2015. The baseline data were collected and NCPAP ventilation were then followed up by operation standards, and the vital signs and arterial blood gas change at special time points were observed and recorded. Any side effect associated with NCPAP were recorded. For categorical variables, comparisons were performed using Fisher test. Rank-sum test and t test were performed respectively for abnormal and normal distribution continuous variables. The variables pre-NCPAP and post-NCPAP were analyzed by repeated measures ANOVA analysis. Result: Totally 145 children were included, and 13 children were excluded due to incomplete data. One hundred and two children(77.3%)were ≤12 months; 91 children (68.9%) were from rural area. NCPAP ventilation was effective in 123 children, with a response rate of 93.2%, were all discharged with a better condition; it was ineffective in 9 children(6.8%), and they were all intubated and went on mechanical ventilation, 5 were discharged with a better condition, and 4 died after gaving up treatment. The gender, age, body weight, residence, main symptoms, main signs, imaging diagnosis, medications, partial pressure of oxygen(PaO(2)), breath and heart rate before NCPAP treatment of two groups had no significant differences(allP>0.05). The rates of combining underlying diseases, trouble with feeding and cyanosis, and the partial pressure of carbon dioxide(PaCO(2) ) before NCPAP ventilation were higher in NCPAP ineffective group ((59±11 )vs.( 49±11) mmHg, 1 mmHg=0.133 kPa, t=-2.597, P=0.028); while the PaO(2)/fraction of inspiration O(2) (FiO(2) ) before NCPAP was lower((150±37) vs. (207±63) mmHg, t=2.697, P=0.008). The breathing, heart rate and PaCO(2) of NCPAP effective group decreased significantly, while the PaO(2) and PaO(2)/FiO(2) increased significantly after 2, 8, 24 h of NCPAP ventilation(all P=0.000). PaCO(2) in children with hypercapnia before NCPAP ventilation in NCPAP effective group decreased significantly ((48±9), (47±12), (45±11)vs.(58±7)mmHg, all P=0.000). All children tolerated well to NCPAP ventilation, and there were no severe side effects or complications associated with NCPAP ventilation. Conclusion: NCPAP ventilation is safe and effectively improved the oxygenation and hypercapnia in infants with CAP. But it may not work well in children with underlying diseases, manifest as difficulty in feeding/cyanosis and extremely high PaCO(2) or low PaO(2)/FiO(2), and they may need early intubation. 目的: 分析5岁以下儿童社区获得性肺炎的临床特点,探讨经鼻持续气道正压通气(NCPAP)对该患病人群治疗的有效性和安全性。 方法: 多中心、前瞻性临床观察性研究。以2013年11月至2015年10月全国6家儿童医院收治的符合NCPAP使用标准的29日龄~5岁社区获得性肺炎患儿为研究对象,记录其基线资料、治疗前后不同时间点动脉血气及生命体征。根据临床转归,分为治疗成功组及未成功组,比较两组患儿在基线资料、应用NCPAP治疗前及治疗后2、8及24 h的动脉氧分压(PaO(2))、动脉血二氧化碳分压(PaCO(2))、心率、呼吸频率、经皮氧饱和度及呼吸机条件是否存在差异;同时观察并记录与NCPAP相关的不良反应。组间比较采用χ(2)检验、t检验或秩和检验、方差分析。 结果: 研究期间共有145例患儿入选,剔除数据不完整13例,最终纳入132例。其中≤12月龄患儿102例(77.3%);农村居民较多,为91例(68.9%)。临床转归方面,NCPAP治疗成功组123例(93.2%);未成功组9例(6.8%),均改为气管插管有创机械通气,其中好转出院5例,死亡4例(均为放弃治疗后死亡)。两组患儿在性别、年龄、体重、居住地、主要症状及阳性体征、影像学诊断和治疗前呼吸频率和心率、治疗前PaO(2)等方面差异均无统计学意义(P均>0.05)。但治疗未成功组患儿在合并基础病、拒奶、发绀等表现上,比例明显多于成功组(P均<0.05);治疗前PaCO(2)明显高于成功组[(59±11)比(49±11)mmHg,1 mmHg=0.133 kPa,t=-2.597,P=0.028];治疗前PaO(2)/吸入氧浓度(FiO(2))明显低于成功组[(150±37)比(207±63) mmHg,t=2.697,P=0.008]。NCPAP治疗2、8、24 h后,成功组患儿呼吸频率、心率、PaCO(2)较治疗前均显著下降(P均=0.000),PaO(2)、PaO(2)/FiO(2)均显著上升(P均=0.000),成功组中治疗前合并高碳酸血症患儿的PaCO(2)均显著下降[(48±9)、(47±12)、(45±11)比(58±7)mmHg,P均=0.000]。所有入选患儿对NCPAP耐受良好,无不良事件或并发症。 结论: 儿童社区获得性肺炎以婴儿期发病较多,以农村居住者为主。规范使用NCPAP安全性高,能有效改善社区获得性肺炎患儿的氧合、缓解高碳酸血症,但对于存在基础疾病、已出现拒奶、发绀、二氧化碳潴留明显、重度低氧血症的患儿,需尽早选择有创通气。.

来源:Zhonghua Er Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu J, Wang Q, Qian SY, et al. [Nasal continuous positive airway pressure ventilation in children with community-acquired pneumonia under five years of age: a prospective, multi-center clinical study]. Zhonghua Er Ke Za Zhi. 2017. PMID: 28482381. doi:10.3760/cma.j.issn.0578-1310.2017.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。